Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 197
of 10Next
1:

In vivo MRI volumetric measurement of prostate regression and growth in mice.

Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ.

BMC Urol. 2007 Jul 24;7:12.

PMID: 17650332 [PubMed - indexed for MEDLINE]

2:

In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models.

Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C.

Prostate. 2006 May 15;66(7):708-17.

PMID: 16425198 [PubMed - indexed for MEDLINE]

3:

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.

Carlani M, Mancino S, Bonanno E, Finazzi Agrò E, Simonetti G.

Radiol Med. 2008 Aug;113(5):670-88. Epub 2008 May 20. English, Italian.

PMID: 18493829 [PubMed - indexed for MEDLINE]

4:

Assessing prostate volume by magnetic resonance imaging: a comparison of different measurement approaches for organ volume analysis.

Jia G, Baudendistel KT, von Tengg-Kobligk H, Heverhagen JT, Polzer H, Henry H, McAuliffe MJ, Levine AL, Rosol TJ, Knopp MV.

Invest Radiol. 2005 Apr;40(4):243-8.

PMID: 15770143 [PubMed - indexed for MEDLINE]

5:

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.

Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.

AJR Am J Roentgenol. 2007 Oct;189(4):849.

PMID: 17885055 [PubMed - indexed for MEDLINE]

6:

Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer.

Hensley H, Quinn BA, Wolf RL, Litwin SL, Mabuchi S, Williams SJ, Williams C, Hamilton TC, Connolly DC.

Cancer Biol Ther. 2007 Nov;6(11):1717-25. Epub 2007 Aug 3.

PMID: 17986851 [PubMed - indexed for MEDLINE]

7:

Visualization and quantification of transplanted Dunning prostate tumors in rats using magnetic resonance imaging.

Rudin M, Qureshi S, Tolcsvai L, Siegel RA.

Prostate. 1988;12(4):333-41.

PMID: 3393495 [PubMed - indexed for MEDLINE]

8:

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. Epub 2007 Sep 19.

PMID: 17881141 [PubMed - indexed for MEDLINE]

9:

Light microscopic morphometric analysis of castration effects in the different lobes of the rat prostate.

Kiplesund KM, Halgunset J, Fjösne HE, Sunde A.

Prostate. 1988;13(3):221-32.

PMID: 3211804 [PubMed - indexed for MEDLINE]

10:

Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate.

Sugimura Y, Cunha GR, Donjacour AA.

Biol Reprod. 1986 Jun;34(5):973-83.

PMID: 3730489 [PubMed - indexed for MEDLINE]

11:

Prostatic growth rate determined from MRI data: age-related longitudinal changes.

Williams AM, Simon I, Landis PK, Moser C, Christens-Barry W, Carter HB, Metter EJ, Partin AW.

J Androl. 1999 Jul-Aug;20(4):474-80.

PMID: 10452590 [PubMed - indexed for MEDLINE]

12:

Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials.

Degrassi A, Russo M, Scanziani E, Giusti A, Ceruti R, Texido G, Pesenti E.

Prostate. 2007 Mar 1;67(4):396-404.

PMID: 17187397 [PubMed - indexed for MEDLINE]

14:

Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI.

Curiel L, Souchon R, Rouvière O, Gelet A, Chapelon JY.

Ultrasound Med Biol. 2005 Nov;31(11):1461-8.

PMID: 16286025 [PubMed - indexed for MEDLINE]

15:

Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning.

Villeirs GM, De Meerleer GO.

Eur J Radiol. 2007 Sep;63(3):361-8. Epub 2007 Aug 1. Review.

PMID: 17683887 [PubMed - indexed for MEDLINE]

16:

Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver.

Inderbitzin D, Gass M, Beldi G, Ayouni E, Nordin A, Sidler D, Gloor B, Candinas D, Stoupis C.

J Gastrointest Surg. 2004 Nov;8(7):806-11.

PMID: 15531233 [PubMed - indexed for MEDLINE]

17:

[MR tomographic monitoring of prostate carcinoma after cryotherapy: initial results]

Hawighorst H, Dörsam J, Knopp MV, Jugowski W, Schoenberg SO, Wiesel M, Essig M, van Kaick G.

Rofo. 1998 Jan;168(1):44-8. German.

PMID: 9501933 [PubMed - indexed for MEDLINE]

18:

Update of prostate magnetic resonance imaging at 3 T.

Kim CK, Park BK.

J Comput Assist Tomogr. 2008 Mar-Apr;32(2):163-72. Review.

PMID: 18379296 [PubMed - indexed for MEDLINE]

19:

Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.

Cirillo S, Petracchini M, D'Urso L, Dellamonica P, Illing R, Regge D, Muto G.

BJU Int. 2008 Aug;102(4):452-8. Epub 2008 May 12.

PMID: 18476973 [PubMed - indexed for MEDLINE]

20:

A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model.

Suttie A, Nyska A, Haseman JK, Moser GJ, Hackett TR, Goldsworthy TL.

Toxicol Pathol. 2003 Jan-Feb;31(1):31-8.

PMID: 12597447 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 197
of 10Next